Rubicon Research — PE Ratio & Valuation Analysis

₹640.20

+0.00%

Current P/E68.60xPrice to earnings

Industry P/E31.77xSector average

⚠️

115.9% Premium to Industry

RUBICON P/E 68.60x vs sector avg 31.77x

💡

Understanding Rubicon Research Valuation

Rubicon Research (RUBICON) currently trades at 68.60x earnings. The Pharmaceuticals sector average PE is 31.77x. RUBICON commands a premium, reflecting high growth expectations. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.

ROE

29.02%

Dividend Yield

0.00%

More on Rubicon Research

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.